Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight

ClinicalTrials.gov ID: NCT04657003

Public ClinicalTrials.gov record NCT04657003. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 12:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Tirzepatide Once Weekly in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-2)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a study of tirzepatide in participants with type 2 diabetes who have obesity or are overweight. The main purpose is to learn more about how tirzepatide affects body weight. The study will last 79 weeks (22 visits).

Study identification

NCT ID
NCT04657003
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
938 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 29, 2021 (Actual)
Primary completion
Mar 16, 2023 (Actual)
Completion
Apr 10, 2023 (Actual)
Last update posted
Apr 8, 2024

2021 – 2023

United States locations

U.S. sites
43
U.S. states
25
U.S. cities
42
Facility City State ZIP Site status
University of Alabama - Department of Nutrition Sciences Birmingham Alabama 35294 —
KLR Business Group, Inc. dba Arkansas Clinical Research Little Rock Arkansas 72205 —
Velocity Clinical Research, Huntington Park Huntington Park California 90255 —
Velocity Clinical Research, Westlake Los Angeles California 90057 —
Catalina Research Institute, LLC Montclair California 91763 —
Encompass Clinical Research Spring Valley California 91978 —
University Clinical Investigators, Inc. Tustin California 92780 —
ALL Medical Research, LLC Cooper City Florida 33024 —
Northeast Research Institute (NERI) Fleming Island Florida 32003 —
New Horizon Research Center Miami Florida 33165 —
West Orange Endocrinology Ocoee Florida 34761 —
Metabolic Research Institute, Inc. West Palm Beach Florida 33401 —
Emory University School of Medicine- Grady Campus Atlanta Georgia 30303 —
East Coast Institute for Research, LLC Macon Georgia 31210 —
Pacific Diabetes & Endocrine Center Honolulu Hawaii 96813 —
Elite Clinical Trials Blackfoot Idaho 83221 —
Rocky Mountain Clinical Research Idaho Falls Idaho 83404 —
American Health Network of Indiana, LLC - Greenfield Greenfield Indiana 46140 —
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265 —
Cotton O'Neil Clinical Research Center Topeka Kansas 66606 —
Maryland Cardiovascular Specialists Baltimore Maryland 21229 —
MD Medical Research Oxon Hill Maryland 20745 —
NECCR PrimaCare Research Fall River Massachusetts 02721 —
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division Troy Michigan 48098 —
Logan Health Research Kalispell Montana 59901 —
Premier Research Trenton New Jersey 08611 —
University of North Carolina Medical Center Chapel Hill North Carolina 27514 —
PharmQuest Greensboro North Carolina 27408 —
Wake Forest University Baptist Medical Center (WFUBMC) Winston-Salem North Carolina 27157 —
Velocity Clinical Research, Cleveland Cleveland Ohio 44122 —
Aventiv Research Dublin Ohio 43016 —
The Corvallis Clinic, P.C. Corvallis Oregon 97330 —
Preferred Primary Care Physicians Uniontown Pennsylvania 15401 —
Center for Neurosciences Warwick Rhode Island 02886 —
Tribe Clinical Research, LLC Greenville South Carolina 29607 —
Texas Diabetes & Endocrinology, P.A. Austin Texas 78749 —
Dallas Diabetes Research Center Dallas Texas 75230 —
Diabetes and Thyroid Center of Fort Worth Fort Worth Texas 76132 —
Juno Research Houston Texas 77040 —
Endocrine Ips, Pllc Houston Texas 77079 —
Health Research of Hampton Roads, Inc. Newport News Virginia 23606 —
Rainier Clinical Research Center Renton Washington 98057 —
Clinical Investigation Specialists Kenosha Wisconsin 53144 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04657003, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 8, 2024 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04657003 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →